| |
| |
|
| Insider
Information: |
Ferro Kevin |
| Relationship: |
|
| City: |
Miami |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
16,007,237 |
|
|
Indirect Shares
|
16,607,959 |
|
|
| Direct
Value |
$1,760,796 |
|
|
|
Indirect Value
|
$1,826,875 |
|
|
| Total
Shares |
32,615,196 |
|
|
| Total
Value |
$3,587,672 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
0.0
|
| Percentage
Gain/Loss : |
 6.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Melinta Therapeutics, Inc |
MLNT |
Director, 10% Owner |
2018-05-29 |
16,007,237 |
2018-05-29 |
16,607,959 |
Premium* |
|
|
Greenhill & Co Inc |
GHL |
|
2023-11-30 |
0 |
2023-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GHL |
Greenhill & Co Inc |
|
• • – |
2023-11-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(54,253) |
0 |
0 |
- |
|
| GHL |
Greenhill & Co Inc |
|
• • – |
2023-11-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(27,242) |
0 |
0 |
- |
|
| GHL |
Greenhill & Co Inc |
Director |
– • – |
2023-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,523 |
27,242 |
0 |
- |
|
| GHL |
Greenhill & Co Inc |
Director |
– • – |
2023-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
3,049 |
23,719 |
0 |
- |
|
| GHL |
Greenhill & Co Inc |
Director |
– • – |
2022-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,261 |
20,670 |
0 |
- |
|
| GHL |
Greenhill & Co Inc |
Director |
– • – |
2022-07-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,389 |
15,409 |
0 |
- |
|
| GHL |
Greenhill & Co Inc |
Director |
– • – |
2022-05-02 |
4 |
B |
$12.15 |
$121,500 |
D/D |
10,000 |
12,020 |
2.39 |
% |
|
| GHL |
Greenhill & Co Inc |
Director |
– • – |
2022-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,020 |
56,273 |
0 |
- |
|
| GHL |
Greenhill & Co Inc |
Director |
– • – |
2022-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,743 |
54,253 |
0 |
- |
|
| GHL |
Greenhill & Co Inc |
Director |
– • – |
2021-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,137 |
52,510 |
0 |
- |
|
| GHL |
Greenhill & Co Inc |
Director |
– • – |
2021-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,008 |
50,373 |
0 |
- |
|
| GHL |
Greenhill & Co Inc |
Director |
– • – |
2021-05-11 |
4 |
B |
$15.90 |
$571,678 |
D/D |
35,937 |
48,365 |
2.39 |
% |
|
| GHL |
Greenhill & Co Inc |
Director |
– • – |
2021-05-07 |
4 |
B |
$15.90 |
$102,078 |
D/D |
6,420 |
12,428 |
2.39 |
% |
|
| GHL |
Greenhill & Co Inc |
Director |
– • – |
2021-03-09 |
4 |
B |
$14.50 |
$61,538 |
D/D |
4,244 |
4,744 |
2.39 |
% |
|
| GHL |
Greenhill & Co Inc |
Director |
– • – |
2021-03-05 |
4 |
B |
$14.85 |
$7,425 |
D/D |
500 |
500 |
2.39 |
% |
|
| MLNT |
Melinta Therapeutics, Inc |
Director |
– • • |
2018-05-29 |
4 |
B |
$5.00 |
$37,500,000 |
D/D |
7,500,000 |
16,007,237 |
3.92 |
- |
|
| MLNT |
Melinta Therapeutics, Inc |
Director |
– • • |
2018-05-29 |
4 |
B |
$5.00 |
$78,785,000 |
I/I |
15,757,000 |
16,607,959 |
2.25 |
- |
|
| MLNT |
Melinta Therapeutics, Inc |
Director |
– • • |
2018-01-05 |
4 |
B |
$13.50 |
$54,000,000 |
I/I |
4,000,000 |
8,729,459 |
2.25 |
- |
|
| MLNT |
Melinta Therapeutics, Inc |
Director |
– • • |
2018-01-05 |
4 |
B |
$13.50 |
$24,000,003 |
D/D |
1,777,778 |
8,507,237 |
3.92 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
